Drug intelligence / Profile preview

tanshinone IIA

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Tanshinone IIA is a lipophilic diterpene quinone and the main active component extracted from the roots of Salvia miltiorrhiza (Danshen), a traditional Chinese medicinal herb. It is widely used in China and neighboring countries for cardiovascular diseases, diabetes, apoplexy (stroke), arthritis, sepsis, and other conditions. Pharmacologically, it exhibits anti-inflammatory, antioxidant, immunomodulatory, anti-tumor/anticancer effects (including inhibition of cell proliferation and induction of apoptosis in various cancer cell lines), as well as protective effects on vascular endothelial cells and smooth muscle cells. Mechanistically, it modulates multiple signaling pathways such as PI3K/Akt/mTOR inhibition, p53 activation, RAF/MEK pathway activation in cancer models; suppresses NF-kappaB activity; downregulates inflammatory mediators like CCL2; regulates immune cell function; inhibits oxidative stress; reduces vascular smooth muscle proliferation/migration; stabilizes atherosclerotic plaques by inhibiting apoptosis/inflammation of VSMCs; inhibits foam cell formation by macrophages. It has also shown renoprotective effects via modulation of fibrotic/inflammatory pathways[1][3][5][7][9][10].

Other names
Dan Shen ketone
02

Targets

CYP19A1 (Aromatase)TOP1 (DNA Topoisomerase I)TOP2A (DNA topoisomerase II)MAOA (Monoamine oxidase A)MAOB (Monoamine oxidase B)CHRM4 (M4)NF-κBAKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TP53 (Cellular Tumor Antigen p53 R175H)

Beyond the preview

Go deeper on tanshinone IIA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tanshinone IIA.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call